MDMA therapies hit a roadblock – what's next?
The US Food and Drug Administration has rejected the psychedelic drug MDMA as a treatment for post-traumatic stress disorder, leading many to wonder whether psychedelic therapies have a future in medicine
The US Food and Drug Administration has rejected the psychedelic drug MDMA as a treatment for post-traumatic stress disorder, leading many to wonder whether psychedelic therapies have a future in medicine
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
